Shareholders meeting

Ref. No.: QHTL/Sec/SE/2026-27/31 August 26, 2026 To, To, The Manager, The Manager, Corporate Services, Corporate Services, BSE Limited, National Stock Exchange of India Limited, 14th floor, P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Security ID: QUICKHEAL Symbol: QUICKHEAL Security Code: 539678 Series: EQ Sub: Notice of the 31st Annual General Meeting ('AGM') of the Company. Dear Sir/Madam, Pursuant to Regulation 30 read with para-A of Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, attached herewith is the Notice of the 31st Annual General Meeting of the Company to be held on Wednesday, September 23, 2026 at 11:30 a.m. (IST) through Video Conference / Other Audio Visual Means. The said Notice forms part of the Integrated Annual Report 2025-26 and is being sent through electronic mode to the shareholders of the Company. The Notice of the 31st Annual General Meeting forming part of the Integrated Annual Report is also available on the website of the Company at: https://www.quickheal.co.in/media/investorrelations/financials/agm-notice-2025-26.pdf Sincerely, For Quick Heal Technologies Limited Vikram Dhanani Compliance Officer Encl: As Above Corporate overview Statutory Reports Financial Statements NOTICE Notice is hereby given that the Thirty First Annual General include a Committee thereof for the time being exercising Meeting of the Members of Quick Heal Technologies Limited the powers conferred on the Board by this resolution) may will be held on Wednesday, September 23, 2026 at 11:30 am IST so determine from time to time upon recommendation of through Video Conferencing (“VC”) / Other Audio Visual Means the Nomination and Remuneration Committee and such (“OAVM”) to transact the following business: remuneration / commission shall be payable even in the event of loss or inadequacy of profits in any financial years, ORDINARY BUSINESS: such remuneration / commission shall be within the limits as prescribed under Section 197 read with Schedule V of the 1. Adoption of Financial Statements: Act or Regulation 17 of the SEBI LODR or any amendment To receive, consider and adopt thereof payable to all Non-Executive Independent Directors for financial year 2025-26. (a) the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, RESOLVED FURTHER THAT in case where any Independent together with the Board’s Report and the Auditors’ Director is appointed during the course of a financial year, Report thereon; and the commission payable to such Director shall be pro-rated based on the number of meetings attended. (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, RESOLVED FURTHER THAT the above remuneration/ together with the Auditors’ Report thereon. commission shall be in addition to the fees payable to the Directors for attending the meetings of the Board or any 2. Appointment of Mr. Sanjay Katkar as a Director liable Committee thereof or for any other purpose whatsoever, to retire by rotation: as may be decided by the Board of Directors and To appoint a Director in place of Mr. Sanjay Katkar (DIN: reimbursement of expenses for participation in the Board 00397277), who retires by rotation and being eligible, offers or any committee meetings.” himself for re-appointment. 4. Re-appointment of Mr. Richard Stiennon as Non- Executive Independent Director. SPECIAL BUSINESS: To consider and, if thought fit, pass the following resolution 3. Remuneration to Non – Executive Independent as a Special Resolution: Directors: “RESOLVED THAT pursuant to the provisions of Sections To consider and, if thought fit, to pass, the following 149, 150, 152 and 161 read with Schedule IV and other resolution as a Ordinary Resolution: applicable provisions, if any, of the Companies Act, 2013 (‘the ‘’RESOLVED THAT pursuant to Sections 197, 198, and all Act’) and the Companies (Appointment and Qualifications other applicable provisions of the Companies Act, 2013 of Directors) Rules, 2014, and SEBI (Listing Obligations and read with rules made thereunder, including any statutory Disclosure Requirements) Regulations, 2015 (SEBI LODR), modification or re-enactment thereof and Schedule V, for including any statutory modification(s) or re-enactment(s) the time being in force (hereinafter referred to as “the Act”) thereof for the time being in force and based on the and Regulation 17(6) of the SEBI LODR and on the basis of recommendation of the Nomination and Remuneration the recommendation of the Nomination and Remuneration Committee and the Board of Directors, Mr. Richard Stiennon Committee and of the Board of Directors, the approval of the (DIN: 09324046), who was appointed as a Non-Executive Shareholders be and are hereby accorded for payment of Independent Director of the Company for a term of five (5) remuneration / commission to the Directors of the Company consecutive years commencing from September 27, 2021 who are neither in the wholetime employment with the to September 26, 2026, and who, being eligible, has offered Company nor Managing Directors of the Company, in such himself for re-appointment, and in respect of whom the manner and up to such extent as the Board of Directors Company has received a notice in writing from a Member of the Company (”the Board” which expression shall also under Section 160 of the Act proposing his candidature for the office of Director, be and is hereby re-appointed as an Quick Heal Technologies Limited 87 Non-Executive Independent Director of the Company, not BY ORDER OF THE BOARD OF DIRECTORS liable to retire by rotation, to hold office for a second term For Quick Heal Technologies Limited of 5 (five) consecutive years commencing from September 27, 2026 to September 26, 2031. Sd/- RESOLVED FURTHER THAT pursuant to the provisions Kailash Katkar of Sections 149, 152, Schedule IV and other applicable Chairman and Managing Director provisions, if any, of the Act and the Companies (DIN: 00397191) (Appointment and Qualifications of Directors) Rules, 2014, Place: Pune as amended from time to time, appointment of Mr. Richard Date: July 30, 2026 Stiennon (DIN: 09324046) who has submitted a declaration that he meets the criteria for independence as provided Registered Office: in Section 149(6) of the Act and Regulation 16(1)(b) of the S. No. 1442 - 1445, Thube Park, Shivajinagar, Pune 411005 SEBI LODR, as an Independent Director of the Company, CIN: L72200MH1995PLC091408 not liable to retire by rotation, for a second term of 5 (five) Tel: +91 20 66813232 consecutive years, be and is hereby approved.” E-mail id: cs@quickheal.co.in Website: www.quickheal.co.in 88 Integrated Annual Report 2025-26 Corporate overview Statutory Reports Financial Statements NOTES (PAN) by every participant in the securities market. Members holding shares in electronic form are, therefore, requested 1. In compliance with the provisions of the Companies to submit their PAN to their Depository Participants with Act, 2013 (“Act”), SEBI LODR and MCA Circulars, the 31st whom they are maintaining their demat accounts. Annual General Meeting of the Company is being held through VC / OAVM. 12. Non-Resident Indian Members are requested to inform MUFG Intime India Private Limited (MUFG Intime), 2. The relevant details of 36(3) of SEBI LODR and Secretarial immediately of a) Change in their residential status on Standards (SS) issued by the Institute of Company return to India for permanent settlement. b) Particulars Secretaries of India, in respect of Director seeking re- of their bank account maintained in India with complete appointment at this AGM is annexed. name, branch, account type, account number and address 3. Explanatory Statement pursuant to Section 102(1) of the of the bank with pin code number, if not furnished earlier. Companies Act, 2013, with respect to [Showing first 8,000 characters — download PDF for full document]